Background Atherosclerosis is a systemic disease involving all the major large arteries, including those to the heart, brain, kidneys, and extremities.
Cardiologists have extensive experience treating atherosclerosis in the coronary arteries.
Increasingly, specialized interventional cardiologists are applying their experience to the treatment of atherosclerosis involving noncoronary arteries as well. PARC is non-profit research organization of interventional cardiologists who have special interest, training, and experience in the study and development of new therapies for peripheral artery atherosclerosis. Our Goals To conduct multicenter clinical trials of endovascular and pharmacologic therapies for peripheral vascular atherosclerosis. To facilitate rapid enrollment of patients to address important clinical problems. To apply expertise derived from the study and treatment of coronary artery disease to peripheral artery disease, including appropriate and expeditious data management using systematic and objective outcomes assessments.